|
PTPN12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.57509999995942E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.04670000000695E-06 |
| Normal-vs-Stage2 |
3.915700E-02 |
| Normal-vs-Stage3 |
1.904490E-03 |
| Normal-vs-Stage4 |
1.442120E-02 |
| Stage1-vs-Stage2 |
2.221400E-01 |
| Stage1-vs-Stage3 |
2.267200E-01 |
| Stage1-vs-Stage4 |
2.271800E-01 |
| Stage2-vs-Stage3 |
7.617000E-01 |
| Stage2-vs-Stage4 |
9.539400E-01 |
| Stage3-vs-Stage4 |
7.970600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.5595399999957E-05 |
| Normal-vs-AfricanAmerican |
1.690020E-02 |
| Normal-vs-Asian |
5.84409999999647E-05 |
| Caucasian-vs-AfricanAmerican |
7.303400E-01 |
| Caucasian-vs-Asian |
9.387900E-02 |
| AfricanAmerican-vs-Asian |
4.758400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.449000E-04 |
| Normal-vs-Female |
4.515099999991E-06 |
| Male-vs-Female |
6.077800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.29339999990863E-07 |
| Normal-vs-Age(41-60Yrs) |
1.576700E-04 |
| Normal-vs-Age(61-80Yrs) |
5.432100E-02 |
| Normal-vs-Age(81-100Yrs) |
5.991900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.197800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.602300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.991200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.054450E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.660000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.147800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.881800E-01 |
| Classical-VS-Follicular |
1.74629999349918E-09 |
| Classical-VS-Other |
3.756200E-01 |
| Classical-VS-Normal |
2.02390000314523E-08 |
| Tall-VS-Follicular |
5.972400E-04 |
| Tall-VS-Other |
4.483000E-01 |
| Tall-VS-Normal |
1.580280E-03 |
| Follicular-VS-Other |
2.663800E-01 |
| Follicular-VS-Normal |
9.807000E-01 |
| Other-VS-Normal |
1.925240E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.281600E-03 |
| Normal-vs-N1 |
2.960500E-04 |
| N0-vs-N1 |
3.473800E-02 |
|
|
